Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles

Luca Vannucci1,*, Elisabetta Falvo2,*, Manuela Fornara3, Patrizio Di Micco4, Oldrich Benada1, Jiri Krizan1, Jan Svoboda1, Katarina Hulikova-Capkova1, Veronica Morea3, Alberto Boffi4,5, Pierpaolo Ceci3 1Institute of Microbiology, Academy of Sciences of the Czech Republic, VVI, Prague, Czech Republic;...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Vannucci L, Falvo E, Fornara M, Di Micco P, Benada O, Krizan J, Svoboda J, Hulikova-Capkova K, Morea V, Boffi A, Ceci P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/ebcd084135a943b7b3917a87369d6d8f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ebcd084135a943b7b3917a87369d6d8f
record_format	dspace
spelling	oai:doaj.org-article:ebcd084135a943b7b3917a87369d6d8f2021-12-02T02:10:29ZSelective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles1176-91141178-2013https://doaj.org/article/ebcd084135a943b7b3917a87369d6d8f2012-03-01T00:00:00Zhttp://www.dovepress.com/selective-targeting-of-melanoma-by-peg-masked-protein-based-multifunct-a9508https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Luca Vannucci1,, Elisabetta Falvo2,, Manuela Fornara3, Patrizio Di Micco4, Oldrich Benada1, Jiri Krizan1, Jan Svoboda1, Katarina Hulikova-Capkova1, Veronica Morea3, Alberto Boffi4,5, Pierpaolo Ceci3 1Institute of Microbiology, Academy of Sciences of the Czech Republic, VVI, Prague, Czech Republic; 2Regina Elena Cancer Institute, Pharmacokinetic/Pharmacogenomic Unit, 3National Research Council of Italy, Institute of Molecular Biology and Pathology, 4Department of Biochemical Sciences &ldquo;A Rossi Fanelli&rdquo;, University of Rome &ldquo;Sapienza&rdquo;, 5Center for Life Nano Science at Sapienza, Italian Institute of Technology, Rome, Italy *These two authors contributed equally to this workBackground: Nanoparticle-based systems are promising for the development of imaging and therapeutic agents. The main advantage of nanoparticles over traditional systems lies in the possibility of loading multiple functionalities onto a single molecule, which are useful for therapeutic and/or diagnostic purposes. These functionalities include targeting moieties which are able to recognize receptors overexpressed by specific cells and tissues. However, targeted delivery of nanoparticles requires an accurate system design. We present here a rationally designed, genetically engineered, and chemically modified protein-based nanoplatform for cell/tissue-specific targeting.Methods: Our nanoparticle constructs were based on the heavy chain of the human protein ferritin (HFt), a highly symmetrical assembly of 24 subunits enclosing a hollow cavity. HFt-based nanoparticles were produced using both genetic engineering and chemical functionalization methods to impart several functionalities, ie, the &alpha;-melanocyte-stimulating hormone peptide as a melanoma-targeting moiety, stabilizing and HFt-masking polyethylene glycol molecules, rhodamine fluorophores, and magnetic resonance imaging agents. The constructs produced were extensively characterized by a number of physicochemical techniques, and assayed for selective melanoma-targeting in vitro and in vivo.Results: Our HFt-based nanoparticle constructs functionalized with the &alpha;-melanocyte-stimulating hormone peptide moiety and polyethylene glycol molecules were specifically taken up by melanoma cells but not by other cancer cell types in vitro. Moreover, experiments in melanoma-bearing mice indicate that these constructs have an excellent tumor-targeting profile and a long circulation time in vivo.Conclusion: By masking human HFt with polyethylene glycol and targeting it with an &alpha;-melanocyte-stimulating hormone peptide, we developed an HFt-based melanoma-targeting nanoplatform for application in melanoma diagnosis and treatment. These results could be of general interest, because the same strategy can be exploited to develop ad hoc nanoplatforms for specific delivery towards any cell/tissue type for which a suitable targeting moiety is available.Keywords: multifunctional nanoparticles, ferritin, nanoplatform, cancer-targeting, melanomaVannucci LFalvo EFornara MDi Micco PBenada OKrizan JSvoboda JHulikova-Capkova KMorea VBoffi ACeci PDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 1489-1509 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Vannucci L Falvo E Fornara M Di Micco P Benada O Krizan J Svoboda J Hulikova-Capkova K Morea V Boffi A Ceci P Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles
description	Luca Vannucci1,, Elisabetta Falvo2,, Manuela Fornara3, Patrizio Di Micco4, Oldrich Benada1, Jiri Krizan1, Jan Svoboda1, Katarina Hulikova-Capkova1, Veronica Morea3, Alberto Boffi4,5, Pierpaolo Ceci3 1Institute of Microbiology, Academy of Sciences of the Czech Republic, VVI, Prague, Czech Republic; 2Regina Elena Cancer Institute, Pharmacokinetic/Pharmacogenomic Unit, 3National Research Council of Italy, Institute of Molecular Biology and Pathology, 4Department of Biochemical Sciences &ldquo;A Rossi Fanelli&rdquo;, University of Rome &ldquo;Sapienza&rdquo;, 5Center for Life Nano Science at Sapienza, Italian Institute of Technology, Rome, Italy *These two authors contributed equally to this workBackground: Nanoparticle-based systems are promising for the development of imaging and therapeutic agents. The main advantage of nanoparticles over traditional systems lies in the possibility of loading multiple functionalities onto a single molecule, which are useful for therapeutic and/or diagnostic purposes. These functionalities include targeting moieties which are able to recognize receptors overexpressed by specific cells and tissues. However, targeted delivery of nanoparticles requires an accurate system design. We present here a rationally designed, genetically engineered, and chemically modified protein-based nanoplatform for cell/tissue-specific targeting.Methods: Our nanoparticle constructs were based on the heavy chain of the human protein ferritin (HFt), a highly symmetrical assembly of 24 subunits enclosing a hollow cavity. HFt-based nanoparticles were produced using both genetic engineering and chemical functionalization methods to impart several functionalities, ie, the &alpha;-melanocyte-stimulating hormone peptide as a melanoma-targeting moiety, stabilizing and HFt-masking polyethylene glycol molecules, rhodamine fluorophores, and magnetic resonance imaging agents. The constructs produced were extensively characterized by a number of physicochemical techniques, and assayed for selective melanoma-targeting in vitro and in vivo.Results: Our HFt-based nanoparticle constructs functionalized with the &alpha;-melanocyte-stimulating hormone peptide moiety and polyethylene glycol molecules were specifically taken up by melanoma cells but not by other cancer cell types in vitro. Moreover, experiments in melanoma-bearing mice indicate that these constructs have an excellent tumor-targeting profile and a long circulation time in vivo.Conclusion: By masking human HFt with polyethylene glycol and targeting it with an &alpha;-melanocyte-stimulating hormone peptide, we developed an HFt-based melanoma-targeting nanoplatform for application in melanoma diagnosis and treatment. These results could be of general interest, because the same strategy can be exploited to develop ad hoc nanoplatforms for specific delivery towards any cell/tissue type for which a suitable targeting moiety is available.Keywords: multifunctional nanoparticles, ferritin, nanoplatform, cancer-targeting, melanoma
format	article
author	Vannucci L Falvo E Fornara M Di Micco P Benada O Krizan J Svoboda J Hulikova-Capkova K Morea V Boffi A Ceci P
author_facet	Vannucci L Falvo E Fornara M Di Micco P Benada O Krizan J Svoboda J Hulikova-Capkova K Morea V Boffi A Ceci P
author_sort	Vannucci L
title	Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles
title_short	Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles
title_full	Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles
title_fullStr	Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles
title_full_unstemmed	Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles
title_sort	selective targeting of melanoma by peg-masked protein-based multifunctional nanoparticles
publisher	Dove Medical Press
publishDate	2012
url	https://doaj.org/article/ebcd084135a943b7b3917a87369d6d8f
work_keys_str_mv	AT vannuccil selectivetargetingofmelanomabypegmaskedproteinbasedmultifunctionalnanoparticles AT falvoe selectivetargetingofmelanomabypegmaskedproteinbasedmultifunctionalnanoparticles AT fornaram selectivetargetingofmelanomabypegmaskedproteinbasedmultifunctionalnanoparticles AT dimiccop selectivetargetingofmelanomabypegmaskedproteinbasedmultifunctionalnanoparticles AT benadao selectivetargetingofmelanomabypegmaskedproteinbasedmultifunctionalnanoparticles AT krizanj selectivetargetingofmelanomabypegmaskedproteinbasedmultifunctionalnanoparticles AT svobodaj selectivetargetingofmelanomabypegmaskedproteinbasedmultifunctionalnanoparticles AT hulikovacapkovak selectivetargetingofmelanomabypegmaskedproteinbasedmultifunctionalnanoparticles AT moreav selectivetargetingofmelanomabypegmaskedproteinbasedmultifunctionalnanoparticles AT boffia selectivetargetingofmelanomabypegmaskedproteinbasedmultifunctionalnanoparticles AT cecip selectivetargetingofmelanomabypegmaskedproteinbasedmultifunctionalnanoparticles
_version_	1718402684748300288

Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles

Ejemplares similares